Marcus Morra, MD
Urology · Rockingham, VANPI 1407926058
Payments from drug & device makers
Across 81 payments — averaging $21.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$237
- Sumitomo Pharma America, Inc.$180
- Urogen Pharma, Inc.$120
- Accord Healthcare, Inc.$107
- Pfizer$89
- Astellas Pharma US Inc$87
- plus $954 from 24 others
What the payments were for
- Food & beverage$1,76099%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $237 |
| Sumitomo Pharma America, Inc. | 6 | $180 |
| Urogen Pharma, Inc. | 5 | $120 |
| Accord Healthcare, Inc. | 3 | $107 |
| Pfizer | 5 | $89 |
| Astellas Pharma US Inc | 4 | $87 |
| Dendreon Pharmaceuticals LLC | 3 | $86 |
| Merck | 4 | $77 |
| Antares Pharma, Inc. | 3 | $74 |
| Myriad Genetic Laboratories, Inc. | 5 | $74 |
| Blue Earth Diagnostics | 3 | $69 |
| Myovant Sciences Inc. | 3 | $68 |
| Tolmar, Inc. | 2 | $59 |
| Rochester Medical Corporation | 3 | $49 |
| Johnson & Johnson | 2 | $47 |
| Cook Medical LLC | 3 | $46 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $38 |
| Urovant Sciences Inc | 1 | $30 |
| AstraZeneca | 1 | $25 |
| Ambu Inc. | 1 | $25 |
| Coloplast | 1 | $24 |
| Tempus AI, Inc | 1 | $23 |
| Novartis | 1 | $20 |
| Tolmar Pharmaceuticals, Inc. | 1 | $20 |
| Photocure Inc | 1 | $20 |
| Vertex | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Teleflex LLC | 1 | $16 |
| Axonics, Inc. | 1 | $13 |
How this compares
$1,775 in reported general payments places this provider in the 40th percentile of 300 urology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 358 | $5,543 |
| Finasteride | 200 | $2,932 |
| Tolterodine Tartrate ErTolterodine Tartrate | 29 | $2,291 |
| Dutasteride | 32 | $1,333 |
| Methenamine Hippurate | 17 | $962 |
| Cephalexin | 76 | $399 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $290 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 19 | $251 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $190 |
| Ciprofloxacin Hcl | 27 | $80 |
| Doxycycline Monohydrate | 12 | $73 |
| Levofloxacin | 16 | $48 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $33 |
Paid to pharmacies, not to this prescriber.
Other urology in Rockingham
- Robert GivenVirginia Beach$8.7M
- Michael WilliamsVirginia Beach$2.7M
- Michael FabrizioVirginia Beach$1.6M
- Gregg EureVirginia Beach$1.5M
- Nilay GandhiWoodbridge$1.3M
- Jessica DelongVirginia Beach$644K
- Eugene KramolowskyRichmond$594K
- Nicolas OrtizCharlottesville$331K
- Stephen CulpCharlottesville$284K
- Michael FranksRichmond$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.